IL6 and long COVID-19: Research conducted by Torres-Ruiz et al. highlighted significantly elevated baseline levels of IL-1α and IP-10, with a trend of higher levels of IL-6, IFN-γ, and IL-1β in patients who later developed PASC as compared to those who recovered from acute infection [96].